Furthermore, elevated levels of GDF15 associated with prostate cancer facilitated bone metastasis and bone turnover, while the deletion of GDF15 in this context inhibited osteoblast differentiation and mineralization [56]. The gene discussed is GDF15; the disease is prostate carcinoma.